Examining medication adherence in older women with coronary heart disease

Journal of Women and Aging

Volumn 22, Issue 3, 2010, Pages 157-170

  West, Donna ^a   Lefler, Leanne ^b   Franks, Amy ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Medication adherence; Medication management; Tailored interventions

Indexed keywords

AGED; ARTICLE; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEALTH STATUS; HUMAN; INTERVIEW; MIDDLE AGED; PATIENT COMPLIANCE; PILOT STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; STATISTICS; WOMEN'S HEALTH;

AGED; COMORBIDITY; CORONARY DISEASE; FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; MEDICATION ADHERENCE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; WOMEN'S HEALTH;

EID: 77954749276     PISSN: 08952841     EISSN: 15407322     Source Type: Journal    
DOI: 10.1080/08952841.2010.495547     Document Type: Article

References (37)

1. Agency for Healthcare Research and Quality. (2009). 2008 National healthcare disparities report. Retrieved from http://www.ahrq.gov/qual
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. (2002). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. Journal of the American Medical Association, 288(23), 2981-2997.
3. American Heart Association. (2009). Heart disease and stroke statistics 2009 update. Dallas, TX: Author.
4. Avorn, J., Monette, J., Lacour, A., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998). Persistence of use of lipid-lowering medications: A cross-national study. Journal of the American Medical Association, 279(18), 1458-1462.
5. Benner, J. S., Glynn, R. J., Mogun, H., Neumann, P. J., Weinstein, M. C., & Avorn, J. (2002). Long-term persistence in use of statin therapy in elderly patients. Journal of the American Medical Association, 288(4), 455-461.
6. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124-133.
7. Centers for Medicare and Medicaid Services. (2010). 2010 Medicare Part D medication therapy management programs. Retrieved from http://www. cms.hhs.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet.pdf
8. Chapman, R. H., Benner, J. S., Petrilla, A. A., Tierce, J. C., Collins, S. R., Battleman, D. S., & Schwartz, J. S. (2005). Predictors of adherence with antihypertensive and lipid-lowering therapy. Archives of Internal Medicine, 165(10), 1147-1152.
9. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L. Jr., Roccella, E. J. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Journal of the American Medical Association, 289(19), 2560-2572.
10. Col, N., Fanale, J. E., & Kronholm, P. (1990). The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Archives of Internal Medicine, 150(4), 841-845.
11. Daughtery, S. L., Ho, P. M., Spertus, J. A., Jones, P. G., Bach, R. G., Krumholz, H. Masoudi, F.A. (2008).Association of early follow-up after acute myocardial infarction with higher rates of medication use. Archives of Internal Medicine, 168,485-491.
12. Eagle, K. A., Kline-Rogers, E., Goodman, S. G., Gurfinkel, E. P., Avezum, A., Flather, M. D., Steg, P. G. (2004). Adherence to evidence-based therapies after discharge for acute coronary syndromes: An ongoing prospective, observational study. American Journal of Medicine, 117(2), 73-81.
13. Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004). Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. Journal of General Internal Medicine, 19(6), 638-645.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 285(19), 2486-2497.
15. Gallagher, E. J., Viscoli, C. M., & Horwitz, R. I. (1993). The relationship of treatment adherence to the risk of death after myocardial infarction in women. Journal of the American Medical Association, 270(6), 742-744.
16. Hays, R. D., Kravitz, R. L., Mazel, R. M., Sherbourne, C. D., DiMatteo, M. R., Rogers, W. H., & Greenfield, S. (1994). The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. Journal of Behavioral Medicine, 17(4), 347-360.
17. Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Rumsfeld, J. S. (2006). Impact of medication therapy discontinuation on mortality after myocardial infarction. Archives of Internal Medicine, 166(17), 1842-1847.
18. Jackevicius, C. A., Li, P., & Tu, J. V. (2008). Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation, 117,1028-1036.
19. Jackevicius, C. A., Mamdani, M., & Tu, J. V. (2002). Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the American Medical Association, 288(4), 462-467.
20. Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Yancy, C. W. (2009). 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. Journal of the American College of Cardiology, 53(15), 1343-1382.
21. Krousel-Wood, M., Hyre, A., Muntner, P., & Morisky, D. (2005). Methods to improve medication adherence in patients with hypertension: Current status and future directions. Current Opinion in Cardiology, 20(4), 296-300.
22. Lee, J. K., Grace, K. A., & Taylor, A. J. (2006). Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol. Journal of the American Medical Association, 296(21), 2563-2571.
23. LIPID: The Long-Term Intervention with Paravastin in Ischaemic Disease Study Group. (1998). Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine, 339(19), 1349-1357.
24. Lorig, K., Stewart, A., Ritter, P., González, V., Laurent, D., & Lynch, J. (1996). Outcome measures for health education and other health care interventions. Thousand Oaks, CA: Sage.
25. Morse, J. M., & Field, P. A. (1995). Qualitative research methods for health professionals (2nd ed.). London, England: Sage.
26. Murawski, M. M., & Bentley, J. P. (2001). Pharmaceutical therapy-related quality of life: conceptual development. Journal of Social and Administrative Pharmacy, 18(1), 2-14.
27. Murray, M. D., Morrow, D. G., Weiner, M., Clark, D. O., Tu, W., Deer, M. M., Weinberger, M. (2004). A conceptual framework to study medication adherence in older adults. American Journal of Geriatric Pharmacotherapy, 2(1), 36-43.
28. Redman, B. K. (2003). Measurement tools in patient education. New York, NY: Springer.
29. Schultz, J. S., O'Donnell, J. C., McDonough, K. L., Sasane, R., & Meyer, J. (2005). Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. American Journal of Managed Care, 11, 306-312.
30. Shaw, B., Cheater, F., Baker, R., Gillies, C., Hearnshaw, H., Flottorp, S., Robertson, N. (2005). Tailored interventions to overcome identified barriers to change. Cochrane Database of Systematic Reviews, 3. doi: 10.1002/14651858
31. Sherbourne, C. D., Hays, R. D., Ordway, L., DiMatteo, M. R., & Kravitz, R. L. (1992). Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study. Journal of Behavioral Medicine, 15(5), 447-468.
32. Simpson, S. H., Johnson, J. A., Farris, K. B., & Tsuyuki, R. T. (2002). Development and validation of a survey to assess barriers to drug use in patients with chronic heart failure. Pharmacotherapy, 22(9), 1163-1172.
33. Smith, D. H., Kramer, J. M., Perrin, N., Platt, R., Roblin, D. W., Lane, K., Soumerai, S. B. (2008). A randomized trial of direct-to-patient communication to enhance adherence to beta blocker therapy following myocardial infarction. Archives of Internal Medicine, 168, 477-483.
34. Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43(6), 521-530.
35. Speziale, H., & Carpenter, D. (2003). Qualitative research in nursing (3rd ed.). Philadelphia, PA: Lippincott.
36. Svarstad, B. L., Chewning, B. A., Sleath, B. L., & Claesson, C. (1999). The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Education and Counseling, 37(2), 113-124.
37. Wei, L., Wang, J., Thompson, P., Wong, S., Struthers, A. D., & MacDonald, T. M. (2002). Adherence to statin treatment and readmission of patients after myocardial infarction: A six year follow up study. Heart, 88(3), 229-233.